Evaluation of the efficacy of peripheral nerve block alone in episodic and chronic migraine patients

dc.authoridEvcili, Gokhan/0000-0003-2965-9936en_US
dc.authoridyabalak, ahmet/0000-0002-3317-9567en_US
dc.authorscopusid55976427000en_US
dc.authorscopusid57284192200en_US
dc.contributor.authorEvcili, Gokhan
dc.contributor.authorYabalak, Ahmet
dc.date.accessioned2024-08-23T16:04:30Z
dc.date.available2024-08-23T16:04:30Z
dc.date.issued2023en_US
dc.departmentDüzce Üniversitesien_US
dc.description.abstractBackground Peripheral nerve block (PNB) is usually performed in patients with migraine who are resistant to treatment with medications.Objective To compare the efficacy of PNB alone and PNB combined with prophylactic medications in migraine patients.Method The data on migraine patients who underwent PNB in our clinic between November 2019 and January 2022 were retrospectively reviewed. Blocks of the greater occipital nerve (GON), lesser occipital nerve (LON) and supraorbital nerve (SON) were performed upon admission and in the second week.Results The study included 116 patients. While 21 out of 39 episodic migraine (EM) patients continued to use prophylactic medications, 18 were followed up with PNB alone. While 49 out of 77 chronic migraine (CM) patients continued to use prophylactic medications, 28 were followed up with PNB alone. Comparison of the admission and second-month data of the patients who only underwent PNB and those who continued the drug treatment together with PNB in both the EM and the CM group showed that the number of days with pain, number of analgesics taken and scores on the Visual Analog Scale (VAS) and the Migraine Disability Assessment (MIDAS) were significantly reduced in both groups ( p < 0.01). Comparison of the second-month data of the patients followed up with PNB alone and those followed up with PNB together with prophylactic medications showed that there was no significant difference between the EM and CM patients ( p > 0.05).Conclusion Bilateral GON, LON and SON block with lidocaine injection seems to be an effective treatment on its own, without the need for prophylactic medications, in both EM and CM patients during a two-month follow-up.en_US
dc.identifier.doi10.1055/s-0043-1771494
dc.identifier.endpage739en_US
dc.identifier.issn0004-282X
dc.identifier.issn1678-4227
dc.identifier.issue8en_US
dc.identifier.pmid37536366en_US
dc.identifier.scopus2-s2.0-85169293330en_US
dc.identifier.scopusqualityQ3en_US
dc.identifier.startpage734en_US
dc.identifier.urihttps://doi.org/10.1055/s-0043-1771494
dc.identifier.urihttps://hdl.handle.net/20.500.12684/14234
dc.identifier.volume81en_US
dc.identifier.wosWOS:001042216900001en_US
dc.identifier.wosqualityQ4en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherAssoc Arquivos Neuro- Psiquiatriaen_US
dc.relation.ispartofArquivos De Neuro-Psiquiatriaen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectMigraine Disordersen_US
dc.subjectNerve Blocken_US
dc.subjectHeadacheen_US
dc.subjectGreateren_US
dc.subjectSensitizationen_US
dc.titleEvaluation of the efficacy of peripheral nerve block alone in episodic and chronic migraine patientsen_US
dc.typeArticleen_US

Dosyalar